
Pfizer plans to move a version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday.
The pharmaceutical giant said it would begin studies evaluating different doses of the treatment later this year.

Pfizer plans to move a version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday.
The pharmaceutical giant said it would begin studies evaluating different doses of the treatment later this year.